As of 2020, the global market for cosmetic surgery and aesthetic medicine is experiencing robust growth, particularly emphasized by the rapid expansion in regions such as Asia-Pacific, which is seeing a growth rate of 10% per annum. The United States retains significant dominance in the market with a 44% share by value, while Brazil leads in terms of the volume of plastic surgery procedures. Non-surgical procedures, especially injectables like hyaluronic acid and botulinum toxin, dominate the market, constituting 38% and showing a projected CAGR of 8.3% through 2026. The market is also seeing an increase in the use of aesthetic devices employing advanced technologies such as non-invasive body reshaping systems. Medical tourism continues to rise, with a 15 to 20% increase registered in 2018, partly driven by cost disparities and the reputation of countries like Brazil for quality aesthetic medicine. Portugal's market can be gauged using data from Italy due to similar per capita spending on beauty products and a relatively comparable number of plastic surgeons per million inhabitants. The Portuguese market accounts for a forecasted 191.3 million euros in 2018, with popular surgical procedures including breast augmentation, liposuction, and rhinoplasty. Regulations remain an area of concern, with instances of practitioners operating without formal aesthetic surgery degrees..Title: Navigating Aesthetic Appeal: Trends in Portugal's Cosmetic Surgery and Medicine Market In recent years, Portugal has shown an increasing interest in cosmetic surgery and aesthetic medicine, reflecting global trends. The market, predominantly featuring non-surgical procedures, has seen a significant rise in demand. In Portugal, non-surgical interventions dominate the aesthetic medicine landscape, accounting for the majority of procedures, predominantly due to their non-invasive nature and lower costs compared to surgical options. Injectables take the lead in non-surgical procedures, with treatments like hyaluronic acid and botulinum toxin comprising nearly 80% of the non-surgical market. As for surgical interventions, operations involving the head, face, and chest are the most common, making up over 70% of procedures, with breast augmentation leading the charge at approximately 20%. Portugal, boasting roughly 25 plastic surgeons per million inhabitants, shows a market concentration similar to that of Italy, suggesting comparable market dynamics between the two countries. Estimates hint at around 145,000 aesthetic procedures being performed in Portugal in a given year, a number derived from the activities in Italy and proportionally adjusted for the Portuguese population. The Portuguese market has embraced medical tourism as well, with a notable influx of patients drawn by the high quality and affordability of procedures, particularly in relation to Brazilian offerings. This trend is fueled by favorable exchange rates making the prospect even more enticing. In terms of distribution, a significant shift can be observed. With a rise in consumer autonomy, there's an increasing prevalence of 'home device' beauty appliances, further democratizing the access to aesthetic improvement options. Additionally, the presence of cosmeceuticals sold online or in pharmacies has highlighted a move towards direct-to-consumer strategies. Prices for various treatments range significantly, from around 20 euros for a session of needle mesotherapy to upwards of 7,000 euros for more complex operations like orthognathic surgery. Regulatory oversight remains a concern, with reports indicating that many practitioners may operate without formal qualifications in aesthetic surgery, a consequence of unrecognized abbreviated training courses in the market. The segmentation of market players is diverse, with major revenue reported by international pharmaceutical companies like Allergan, registering revenue between 15 and 20 billion US dollars, alongside dermatocosmetic laboratories and manufacturers of medical and surgical equipment also playing key roles in the industry. The ongoing trends in Portugal's market reveal a vibrant demand for cosmetic enhancements, underscored by the popularity of non-surgical treatments, a budding medical tourism.### Key Market Players in the Cosmetic Surgery and Medicine Industry The landscape of the cosmetic surgery and medicine market is characterized by the presence of notable companies that range from pharmaceutical giants to specialized medical equipment manufacturers. These players have a profound influence on the industry through their innovative products and services that cater to a growing global demand for both surgical and non-surgical aesthetic treatments. **Allergan plc** Allergan stands out as a powerhouse in the pharmaceutical sector with a wide array of products that span across different medical fields, including aesthetic medicine. Renowned for their brand Botox, a name synonymous with anti-wrinkle treatments, Allergan has firmly positioned itself as a leader in injectables, paralleled by a comprehensive portfolio in other aesthetic solutions. **Silimed** Despite not having visibility on their revenue, Silimed has a reputation for being a prominent player, particularly known for their silicone implants. They cater to the plastic surgery segment, emphasizing safety and innovation in the design and fabrication of their products to meet the aesthetic demands of patients. **Pierre Fabre** Pierre Fabre is a well-respected name in the dermocosmetic laboratories category. It provides an intersection of pharmaceutical rigor with the touch of cosmetic care, bringing to the market a diverse range of skin and body care treatments that are scientifically crafted and have a strong grounding in dermatology. **La Roche-Posay** La Roche-Posay is another influential entity within the dermocosmetic space. Their products are particularly catered towards sensitive skin, featuring thermal spring water from La Roche-Posay in France as a key ingredient, which is known for its natural healing properties. The company's commitment to dermatologically tested skin care solutions has earned them a trusted place among consumers and professionals alike. **Sebbin** Sebbin is a name that reverberates within the surgical equipment domain, especially known for their high-quality implants and expanders used in cosmetic and reconstructive surgery. Their European roots showcase a commitment to excellence and adherence to strict safety standards, producing devices that enhance patient aesthetics and comfort. **Arion** Arion, although not disclosing revenue, is part of the industry's fabric as a manufacturer of medical and surgical equipment. They have dedicated themselves to improving the field of aesthetic medicine through advanced technological solutions in their products, including a variety of implants that cater to a myriad of patient needs. These companies form the backbone of an industry that thrives on the pursuit of beauty and well-being. From inject
Get all the information you need
to understand this market

Detailed content


  • Number of pages : 30 pages
  • Format : Digital and PDF versions
  • Last update : 10/11/2020
Update Details

Summary and extracts

1 Market Overview

1.1 Introduction and market definition

The market of medicine and cosmetic surgery includes several distinct segments:

  • Plastic surgery the technique of reshaping the body through surgical procedures to correct a morphological abnormality or the external appearance of the patient's body;
  • Aesthetic medicine which represents all non-surgical advice, care and treatment designed to improve a patient's aesthetic appearance;
  • Cosmetic products situated halfway between cosmetics and medicines, which contain active ingredients that allow a specific dermatological treatment (wrinkles, dark circles under the eyes, etc.).

Therefore, cosmetic surgery only concerns operations on patients' bodies, such as breast surgery, the most popular procedure. Aesthetic medicine, on the other hand, can be practiced by general practitioners or specialists. The vast majority of cosmetic medicine procedures involves injections under the skin, for example, to reduce wrinkles. Cosmeceuticals are most often used to correct skin aging, although their effectiveness is yet to be proven.

The global cosmetic surgery and medicine market is growing in full swing. This growth is driven in particular by the dynamism of the Asian regions, which are currently the main focus of global demand. However, the market is still largely dominated by the United States and Brazil. For these countries, major players include Allergan plc, Alma Lasers, Anika Therapeutics, Inc. e Merz Aesthetics Inc.

Portugal, for its part, is an interesting market to study, because although there is real domestic demand, several tension points are also evident.

1.2 The world market

As the market can be defined in many different ways, depending on which segments we decide to include or not, the size of the overall market varies greatly depending on the sources used. For this study, we will focus on plastic surgery and non-invasive aesthetic medicine (***). Thus, in the market sizes ...

1.3 The Portuguese market of aesthetic medicine

There are very few official statistics on aesthetic medicine in Portugal. However, we can rely on other countries to make estimates about the Portuguese market. In fact, the main source of statistics on aesthetic medicine is ISAPS(***), it turns out that there are approximately ** plastic surgeons per million inhabitants in ...

2 Demand Analysis

2.1 Typology of demand

Using the distribution of Italian aesthetic procedures given by ISAPS, we can make estimates for Portugal:

Breakdown of aesthetic medicine procedures Estimate for Portugal, ****, % Source: ****

We can see that non-surgical procedures are in the majority, certainly because they are less expensive and less invasive. Let us now look at the distribution ...

2.2 Medical tourism

Medical tourism is an increasingly common practice in the world of cosmetic surgery. According to a study conducted by Patients Beyond Borders, medical tourism increased by ** to **% in ****. This phenomenon is mainly related to the difference in prices between countries. In addition, the recognized quality of Brazilian aesthetic medicine and the ...

3 Market structure

3.1 Production of plastic surgery and aesthetic medicine equipment

The production of equipment for aesthetic purposes includes the manufacture of breast prostheses, injectable products, equipment and finally cosmeceuticals. As the aesthetic market requires high entry costs and advanced technology, most manufacturers are in the production of one of these segments.

As the major players in the market are international groups, ...

3.2 Multi-channel distribution and increased autonomy of final consumers

Clients seeking cosmetic medical treatment may go to hospitals or other practices in the event that the treatment requires professional intervention (***). However, not all treatments fall into this category. There are more and more processes that customers can do independently, not to mention the entire cosmeceutical segment that customers find directly ...

4 Supply analysis

4.1 Prices

Non-surgical procedures:

Source: ****

Surgical procedures:

5 Regulation

5.1 Regulation

Plastic surgery is governed by the laws relating to the Medical Order.

However, the president of the Sociedade Portugesa de Cirurgia Plástica, Reconstrutiva e Estética (***) acknowledges in an interview that many surgeons act without having a degree in aesthetic surgery. This is due to the existence of many short ...

List of charts

  • The global aesthetic medicine market by value
  • Per capita spending on beauty products
  • Breakdown of aesthetic medicine procedures
  • Breakdown of aesthetic surgery procedures
  • Breakdown of non-surgical procedures

All our studies are available online in PDF format

Take a look at an example of our research on another market!

Do you have a question about this study?   +44 238 097 0676

Latest news

Medicine, Allergan Aesthetics launches training center for healthcare professionals - 26/06/2023

Inauguration of Allergan Aesthetics' Center of Excellence in Italy, specifically in Rome. This center represents the first and only space completely dedicated to both theoretical and practical training of healthcare professionals. Its foundation is supported by the expertise of a multidisciplinary scientific committee composed of 21 nationally and internationally renowned experts. The main goal of the center is to offer high-quality training to healthcare professionals through 4 complementary curricula in order to ensure maximum satisfaction of their patients.

"The potential of dermocosmetics is immense", says L'Oréal - 11/05/2023
  • One in four people has a skin problem.
  • After the age of 60, it affects one in two.
  • L'Oréal's dermocosmetics division posted sales of 5 billion euros, with growth of 22%.
  • The dermocosmetics segment represents 8% of the global beauty market, compared with 5% a few years ago.
  • L'Oréal's growth last year was two and a half times faster than the market.
  • La Roche-Posay and CeraVe are brands with sales of over €1 billion.
La Roche-Posay wants to grow by relying on dermatologists. - 02/01/2023
  • Leader in L'Oréal's active cosmetics division
  • Strong organic growth for several years
  • Leader in dermo-cosmetics brands
  • 100 clinical studies by 2022
  • Two billion people worldwide suffer from skin problems
  • The L'Oréal group's cosmetics division achieved sales of €3.9 billion in 2021
  • In China, it will launch a premium regenerative medicine range in a year's time
The Sebbin group is investing in the Val d'Oise to double its size in the next five years. - 04/02/2022
  • Manufacturer of silicone breast implants for cosmetic surgery (70%) and reconstructive surgery (30%)
  • 188 employees
  • Objective: increase production by 50
  • Sebbin generates 80% of its sales internationally through its own distribution subsidiaries, located mainly in England, Germany, Spain and the Netherlands

Companies quoted in this study

This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :

Allergan plc
La Roche-Posay
Laboratoires Sebbin
Filorga Cosmétiques (Colgate Palmolive)

Choosing this study means :

Access to more than 35 hours of work

Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.

Benefit from 6 years' experience and over 1,500 industry reports already produced

Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.

Our know-how and methodology enable us to produce reports that offer unique value for money.

Access to several thousand articles and paid-for data

Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).

To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)

Guaranteed support after your purchase

A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676

A digital format designed for our users

Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.

Our offers :

the aesthetic medicine market | Portugal

89 €
  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What is the positioning of companies in the value chain?
  • Data from several dozen databases

5 reports pack (-15%) PT Portugal

75.6 € / study
378 € instead of 445 € -15%
  • 5 reports at €75.6 excluding VAT per study to choose from our Portuguese catalogue for 12 months
  • Save 15% on additional studies purchased
  • Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)

See the terms and conditions of the pack and the refund of unused credit.


Our customer references

They have consulted our studies Discover the opinions (+500)

Malcolm Vincent
Linkedin logo

Malcolm Vincent

Astoria Finance

Gregoire de Castelnau
Linkedin logo

Gregoire de Castelnau

Stags Participations

Timothé Huignard
Linkedin logo

Timothé Huignard


Paul-Alexis Kebabtchieff
Linkedin logo

Paul-Alexis Kebabtchieff


Aymeric Granet
Linkedin logo

Aymeric Granet

Publicis Consultant

interviews & case studies All interviews and case studies (45)

La pépite Interview

BFM Business

Paul-Alexis Kebabtchieff

Boston Consulting Group

Marie Guibart

Kea Partners

Elaine, Durand

Crédit Agricole, Information & Veille

Philippe Dilasser

Initiative & Finance

Anne Baudry


Amaury Wernert

Kroll (Duff & Phelps)

Smart Leaders Interview


Do you have a question ?
Our team is at your disposal at   +44 238 097 0676